Table 3 |
|
|
Measurement methods |
|
|
Measurement |
Measurement method |
|
|
|
|
BMD |
DXA (QDR4500, Hologic Inc., Bedford. MA) |
|
NTX TRACP-5b |
ELISA (Alere Medical, Japan) ELISA (DS Pharma Biomedical, Japan) |
|
PICP |
ELISA (Takara, Japan) |
|
RANKL |
ELISA (Biomedica, Vienna, Austria) |
|
|
|
|
BMD, bone mineral density; NTX, N-terminal telopeptide of type I collagen; TRACP-5b, tartrate-resistant acid phosphate-5b; PICP, C-terminal propeptide of type I procollagen; RANKL, receptor activator of NF-κB ligand; DXA, dual-energy x-ray absorptiometry; ELISA, enzyme-linked immunosorbent assay. |
|
|
Nagashima et al. Arthritis Research & Therapy 2012 14:R224 doi:10.1186/ar4063 |
|
